massimo broggini
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Specialty Chief Editor
Cancer Molecular Targets and Therapeutics
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Specialty Chief Editor
Cancer Molecular Targets and Therapeutics
Warren Alpert Medical School, Brown University
Providence, United States
Specialty Chief Editor
Cancer Molecular Targets and Therapeutics
Brain Institute of America
New Haven, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
King Saud University
Riyadh, Saudi Arabia
Associate Editor
Cancer Molecular Targets and Therapeutics
National Cancer Institute (NIH)
Rockville, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Auburn University
Auburn, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
United Arab Emirates University
Al-Ain, United Arab Emirates
Associate Editor
Cancer Molecular Targets and Therapeutics
Georgetown University
Washington, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Texas Southwestern Medical Center
Dallas, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Toronto
Toronto, Canada
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Medicine and Pharmacy Iuliu Hatieganu
Cluj-Napoca, Romania
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Kentucky
Lexington, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Center for Cancer Research, National Cancer Institute (NIH)
Bethesda, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Thomas Jefferson University
Philadelphia, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Associate Editor
Cancer Molecular Targets and Therapeutics
Uniformed Services University of the Health Sciences
Bethesda, United States
Associate Editor
Cancer Molecular Targets and Therapeutics